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Abstract
Purpose: Frequently, three-dimensional (3D) conformal beams are used in lung cancer stereotactic body
radiotherapy (SBRT). Recently, volumetric modulated arc therapy (VMAT) was introduced as a new treatment
modality. VMAT techniques shorten delivery time, reducing the possibility of intrafraction target motion. However
dose distributions can be quite different from standard 3D therapy. This study quantifies those differences, with
focus on VMAT plans using unflattened photon beams.
Methods: A total of 15 lung cancer patients previously treated with 3D or VMAT SBRT were randomly selected. For
each patient, non-coplanar 3D, coplanar and non-coplanar VMAT and flattening filter free VMAT (FFF-VMAT) plans
were generated to meet the same objectives with 50 Gy covering 95% of the PTV. Two dynamic arcs were used in
each VMAT plan. The couch was set at ± 5° to the 0° straight position for the two non-coplanar arcs. Pinnacle
version 9.0 (Philips Radiation Oncology, Fitchburg WI) treatment planning system with VMAT capabilities was used.
We analyzed the conformity index (CI), which is the ratio of the total volume receiving at least the prescription
dose to the target volume receiving at least the prescription dose; the conformity number (CN) which is the ratio
of the target coverage to CI; and the gradient index (GI) which is the ratio of the volume of 50% of the
prescription isodose to the volume of the prescription isodose; as well as the V20, V5, and mean lung dose (MLD).
Paired non-parametric analysis of variance tests with post-tests were performed to examine the statistical
significance of the differences of the dosimetric indices.
Results: Dosimetric indices CI, CN and MLD all show statistically significant improvement for all studied VMAT
techniques compared with 3D plans (p < 0.05). V5 and V20 show statistically significant improvement for the FFF-
VMAT plans compared with 3D (p < 0.001). GI is improved for the FFF-VMAT and the non-coplanar VMAT plans
(p < 0.01 and p < 0.05 respectively) while the coplanar VMAT plans do not show significant difference compared
to 3D plans. Dose to the target is typically more homogeneous in FFF-VMAT plans. FFF-VMAT plans require more
monitor units than 3D or non-coplanar VMAT ones.
Conclusion: Besides the advantage of faster delivery times, VMAT plans demonstrated better conformity to target,
sharper dose fall-off in normal tissues and lower dose to normal lung than the 3D plans for lung SBRT. More
monitor units are often required for FFF-VMAT plans.
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Studies have shown encouraging results when treating
medically inoperable early stage lung cancer using stereo-
tactic body radiotherapy (SBRT) [1-3]. Conventionally,
lung cancer SBRT has been delivered using three-dimen-
sional (3D) non-coplanar beams [4] or IMRT. Recently,
volumetric modulated arc therapy (VMAT) was intro-
duced to treat various disease sites [5-7], including lung
SBRT [8,9]. The major advantages of the VMAT SBRT
plans compared to the conventional 3D ones include faster
delivery, which reduces the risk of intrafractional motion,
while simultaneously improving target dose conformity
[8,9]. VMAT plans lead to a smaller percentage of lung
volume exceeding 5 Gy, (V5), and 20 Gy, (V20) [10].
Recently, a flattening-filter-free (FFF) linear accelerator
was installed in our clinic. As part of critical evaluation of
this new technology, we included FFF-VMAT into com-
prehensive comparisons of the dosimetric parameters for
different lung SBRT treatment techniques. We studied the
dose conformity to the target volume, the dose fall-off in
normal tissues, and the V20, V5, mean lung dose (MLD),
mean PTV dose, as well as total monitor units (MU) for
VMAT, FFF-VMAT and 3D conformal SBRT plans. In the
present paper, we statistically compare these techniques.
Materials and methods
Treatment planning
This retrospective study was approved by the institutional
IRB. A total of 15 early stage lung cancer patients with var-
ious tumor sizes previously treated with 3D or VMAT
SBRT were randomly selected. Four-dimensional (4D) CT
was used for each patient to determine the internal gross
tumor volume (IGTV) to account for the respiratory
motion. Abdominal compression was applied to thirteen
patients to minimize respiratory excursion of the dia-
phragm. For two patients, no abdominal compression was
applied, at the discretion of the treating radiation oncolo-
gist. A superior/inferior margin of 0.7 cm and axial margin
of 0.5 cm was added to the IGTV to generate the planning
target volume (PTV). The average PTV was 61.0 cm
3
(range 16.8-160.8 cm
3). For each patient, we generated a
non-coplanar 3D plan, both coplanar and a non-coplanar
conventional VMAT plans, and a non-coplanar FFF-
VMAT plan. The same dose objectives were used for each
plan. They were designed to deliver 50 Gy in 5 fractions to
9 5 %o ft h eP T V .T w od y n a m i ca r c sw e r eu s e di na l l
VMAT plans. The couch was offset ± 5° for the non-copla-
nar arcs. Pinnacle version 9.0 (Philips Radiation Oncology,
Fitchburg WI) was used to plan for a 6 MV or 6MV-FFF
beams from a TrueBeam linear accelerator (Varian Medical
System Inc. Palo Alto, CA). SmartArc was used for the
VMAT planning [11]. All plans were designed to spare the
contralateral lung as much as possible. To that end, no arc
beam entrance through the uninvolved lung was allowed.
Thus no full rotation arcs were used. The same beam
entrance strategy was also used in the 3D plans, with 9-11
beams, of which 4-9 were non-coplanar. A 1 cm wide
avoidance ring structure was used in plan optimization to
facilitate rapid dose fall-off away from the PTV. The Pinna-
cle’s direct machine parameters optimization (DMPO) fea-
ture was used in the beam weighting optimization by
allowing one segment per beam for the 3D plans. Inhomo-
geneity correction was used in all the plans.
Conformity index
The conformity index (CI) is defined as the ratio of the
total volume receiving at least the prescription dose, V100,
to the target volume receiving at least the prescription
dose, Vt100:[12]
CI = V100/Vt100 (1)
The value of CI is always greater than unity. A value
that is closer to unity represents a better target confor-
mity of radiation dose in the treatment plan.
Conformity number
The target coverage (TC) is defined as the ratio of the
target volume receiving at least the prescription dose,
Vt100, to the total target volume, Vt:
TC = Vt100/Vt (2)
The value of CI varies with the value of TC. Poor target
coverage may give a better CI. To include the effect of TC
on conformity, the conformity number (CN) is introduced
and defined as the ratio of the TC to CI [13]:
CN = TC/CI = Vt2
100/(V100 · Vt) (3)
The value of CN is always smaller than unity. A value
closer to unity represents a better conformity and target
coverage.
Gradient index
The gradient index (GI) is defined as the ratio of the
volume covered by at least a given percentage of the pre-
scription dose to the volume covered by the full prescrip-
tion dose [14]. For this lung SBRT dosimetric study, the
given percentage is set at 50% of the prescription dose.
Mathematically, GI in this study is expressed as:
GI = V50/V100 (4)
where V50 is the volume covered by at least 50% of
the prescription dose.
The value of GI is greater than unity. A value that is
closer to unity represents a faster dose fall-off in normal
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dose to critical structures.
V20, V5, and Mean Lung Dose
The percentage of normal lung volume exceeding 20 Gy
of dose, V20, is a key parameter in risk assessment of
radiation pneumonitis [15], and is often used in thoracic
cancer treatment plan evaluation [1,16]. Other studies
also found close correlation between high percentage
normal lung volume exceeding 5 Gy of dose (V5) and
pneumonitis [17,18]. Normal lung volume was defined as
the total lung volume minus GTV. Our treatment plan-
ning objectives required a V20 < 10%. The mean lung
dose (MLD) is another important index in radiation
pneumonitis risk assessment [19]. The values of V20, V5
and MLD were compared between the planning methods
for each case. The generalized equivalent uniform dose
(gEUD) [20,21] was calculated for normal lung volume
and compared between all the plans.
Total monitor units
At distances beyond a few cm from the field edge, periph-
eral dose is dominated by accelerator head leakage and is
therefore proportional to total MU. Monitor units in each
plan were compared as a risk index for potential radiation-
induced secondary malignancies [22]. The accelerators are
calibrated to deliver 1 cGy/MU to muscle at a depth of
maximum dose (1.5 cm) for a 10 × 10 field at source-to-
surface distance of 100 cm.
Mean dose in PTV
The mean target dose (MTD) was used to quantify dose
h o m o g e n e i t yi n s i d et h eP T V .W i t ht h es a m ep r e s c r i b e d
dose and target coverage, higher MTD implies a more het-
erogeneous dose distribution within the PTV. Addition-
ally, the gEUD was calculated for the PTV based on the
dose distribution and compared between all the plans.
Statistical analysis
The non-parametric Friedman test was applied in the sta-
tistical analysis. The Friedman test compares three or
more paired groups. A p value is generated by the Fried-
man test. If it is small (< 0.05), the null hypothesis that
there is no difference between the column median values
is rejected. The paired test is chosen because the underly-
ing physical problem is identical across the planning
techniques for each patient but varies among the
patients.
Following the Friedman test, the rank-based multiple
comparison test, Dunn’s post-test, was performed. It tests
the same null hypothesis for individual pairs of data col-
umns. Dunn’s post-test includes a non-parametric
equivalent of Bonferroni adjustment for multiple
comparisons.
Results
Table 1 lists the statistical data of the dosimetric indices
for all the studied cases. Overall, VMAT plans demon-
strate better indices than the 3D plans. The non-coplanar
VMAT plans yield slightly better indices than the coplanar
ones. The GI values for the FFF-VMAT plans were slightly
lower than those for conventional plans. VMAT required
higher total MUs than 3D. The FFF-VMAT plans tended
to use the highest number of MU.
Due to the large differences in PTV size as well as indivi-
dual patient anatomical variations, the standard deviations
in Table 1 are quite high. This large spread somewhat
obscures the dosimetric differences between the plans. To
better illuminate the differences, all the plans were com-
pared with the corresponding 3D plans taken as a refer-
ence. The numbers of cases out of the 15 cases studied
that dosimetrically favor the VMAT or FFF-VMAT plans
are presented in Table 2. Except for the total MUs, more
cases favor the VMAT and FFF-VMAT plans for all other
dosimetric indices.
Conformity index (CI)
The overall Friedman test demonstrated highly significant
difference between the techniques (p < 0.0001) for the CI.
Individual comparisons (Dunn’s post-test) for the CI indi-
cate statistically significant difference between the 3D and
all VMAT techniques: p < 0.05 between the 3D and the
coplanar VMAT plans, p < 0.01 between 3D and the non-
coplanar VMAT plans and p < 0.001 between 3D and the
FFF-VMAT plans,. The differences were not significant
(p > 0.05) between different VMAT plans. VMAT offers
statistically significant improvement in CI over 3D.
Conformity number (CN)
Similar to CI, the Friedman test indicated overall signifi-
cant difference in CN (p < 0.0001). The p values of the
Dunn’s post-test were p < 0.05 between 3D and the copla-
nar VMAT plans, p < 0.01 between 3D and the non-copla-
nar VMAT plans and p < 0.001 between 3D and the FFF-
VMAT plans. No significant difference in CN between
VMAT techniques could be established (p > 0.05)
Gradient index (GI)
The overall p value from the Friedman test was 0.0035
for GI. The Dunn’s test yielded p < 0.05 between 3D and
the non-coplanar VMAT plans and p < 0.01 between 3D
and the FFF-VMAT plans. The test demonstrated no sig-
nificant GI improvement (p > 0.05) for coplanar VMAT
compared to 3D, and no significant differences among
the different VMAT techniques.
V20, V5 and mean lung dose (MLD)
From the overall Friedman test, p < 0.0001 for V20. A
statistically significant improvement in V20 was found
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0.001) techniques compared to 3D. No significant differ-
ence in V20 was found between 3D and coplanar
VMAT, as well as between different VMAT techniques.
The Friedman test yielded p = 0.0002 for V5 compari-
sons. Individual comparisons showed no statistically sig-
nificant differences, except for the FFF-VMAT plans
indicating improvement in V5 compared to 3D (p <
0.001).
The Friedman test was significant (p < 0.0001) for MLD
comparisons. The Dunn’s post test demonstrated that all
VMAT techniques showed improvement in MLD com-
pared to 3D with p < 0.05 between 3D and the coplanar
VMAT, p < 0.01 between 3D and the non-coplanar
VMAT and p < 0.001 between 3D and FFF-VMAT. No
significant difference inM L Dw a ss h o w nb e t w e e nt h e
VMAT techniques. The gEUDs for the normal lung clo-
sely followed the MLD.
Monitor units (MU)
The overall Friedman test p value for the MU was p <
0.0001. The MUs were significantly different between
FFF-VMAT and 3D (p < 0.001) and between FFF-VMAT
and non-coplanar VMAT (p < 0.05). There was also a
difference between 3D and coplanar VMAT (p < 0.001).
The MU in the FFF-VMAT plans was always greater
than in 3D plans.
Mean dose in PTV (MTD)
The average MTD was lowest in the FFF-VMAT plans.
The p value from the Friedman test for MTD was 0.0052.
The Dunn’s test only showed significant difference
between the coplanar VMAT and FFF-VMAT techniques
(p < 0.01). These are the planning techniques with the
highest and lowest average MTD values. The compari-
sons of the PTV gEUD closely followed the MTD
comparisons.
Discussion
The VMAT advantage in shortening the treatment time
compared to 3D non-coplanar plans is well known [9].
The current study also shows that VMAT plans are more
likely to give statistically better target conformity and shar-
per dose fall-off in normal tissues. The average GI value
for FFF-VMAT plans was lower than that for 3D plans,
indicating better dose fall-off in normal tissues in the FFF-
VMAT plans. At the same time, V20 and V5 were lower
when treating with FFF-VMAT. V20 was also lower in
non-coplanar VMAT plans than in 3D.
In general, the comparison of V20, V5 and MLD
between VMAT and 3D in this study agrees with the
study by McGrath et al [23], but not with Chan et al [24].
In Chan et al, the comparison was made for the treatment
of the locally advanced non-small cell lung cancer. The
target volume was usually larger than is suitable for SBRT.
In their comparison, mean lung dose and V20 were similar
between 3D and VMAT, but V5 was significantly higher in
VMAT. The comparison of other parameters in Chan
et al, such as CI and MU, agree with our study.
Due to collision limitations, the angle separation of the
non-coplanar arcs was uniformly set at 10° (± 5° to the
straight couch position). It is plausible that the dosimetric
differences between the coplanar and non-coplanar
VMAT plans were not statistically significant due to this
small physical angle separation as opposed to the limited
statistical power. We further postulate that with a larger
angle separation, the differences are expected to increase,
favoring the non-coplanar VMAT plans for the CI, GI and
Table 1 Dosimetric data of 3D, coplanar, non-coplanar VMAT and FFF-VMAT plans
Plan 3D Coplanar VMAT Non-coplanar VMAT Non-coplanar FFF-VMAT
CI 1.44 ± 0.21 1.23 ± 0.20 1.22 ± 0.17 1.19 ± 0.13
CN 0.67 ± 0.09 0.79 ± 0.09 0.79 ± 0.08 0.81 ± 0.07
GI 7.12 ± 1.43 6.49 ± 1.90 6.41 ± 1.78 6.23 ± 1.59
V20 (%) 6.8 ± 2.9 5.8 ± 2.4 5.8 ± 2.3 5.6 ± 2.3
V5 (%) 23.5 ± 8.0 20.9 ± 7.4 21.0 ± 7.2 20.4 ± 7.1
MLD (cGy) 497 ± 153 458 ± 144 459 ± 140 449 ± 142
MTD (cGy) 5359 ± 101 5370 ± 116 5361 ± 104 5324 ± 83
MU 1528 ± 136 1708 ± 194 1660 ± 200 1805 ± 258
In the table, CI = conformity index, CN = conformity number, GI = gradient index, V20 is the percentage volume of lung-GTV exceeding 20 Gy, V5 is the
percentage volume of lung-GTV exceeding 5 Gy, MLD = mean lung dose, MTD = mean target dose and MU = number of monitor units.
Table 2 Compared to 3D plans, number of cases that is
dosimetrically in favor of the VMAT or FFF plans
Index CI CN GI V5 V20 MLD MTD MU
Coplanar VMAT 14 14 12 12 13 15 5 0
Non-coplanar VMAT 14 14 12 13 14 14 8 2
Non-coplanar FFF-VMAT 15 15 13 14 15 14 11 0
The total number of cases is 15. In the table, CI = conformity index, CN =
conformity number, GI = gradient index, V20 is the percentage volume of
lung-GTV exceeding 20 Gy, V5 is the percentage volume of lung-GTV
exceeding 5 Gy, MLD = mean lung dose, MTD = mean target dose and MU =
number of monitor units.
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ler patients or when the tumor is situated more laterally.
The other way to increase the angle separation is to shift
the isocenter laterally, away from the tumor. We have not
explored this option.
Beam arrangements are more restrictive in VMAT plan-
ning compared to 3D conformal planning. First, the couch
angle range for non-coplanar planning is smaller with the
arcs compared to the static beams. Second, the machine
limitation prohibiting the gantry from crossing the 180
degree position often shortens the arc length in VMAT
planning, as shown in Figure 1. This could affect the qual-
ity of the VMAT plans.
If increased dose heterogeneity is accepted within the
target volume, dose fall-off can be sharpened in normal
tissue [25]. Because FFF-VMAT plans tend to deliver a
more homogeneous dose to the target volumes, the GI
should be improved if the dose constraints mandate a
higher mean dose in the targets. The other factor that
affects the dose fall-off in normal tissue is the beam aper-
ture margin. In SmartArc planning, this margin is not
fixed, but is rather optimized by the software. An option
to allow user to use a fixed margin with the arcs would
help to improve the dose fall-off in normal tissue.
For off-center PTV volumes, FFF-VMAT typically
requires more MU due to the highly peaked beam profile.
This does not automatically translate into higher periph-
eral doses as there is less head scatter and leakage from
an accelerator without a flattening filter [26].
The dose rate for the FFF beams can be substantially
higher than the conventional beams (1400 or 2400 MU/
min vs. 600-1000 MU/min). However, for VMAT plans,
the treatment delivery time is largely limited by the gan-
try rotation speed, not the dose rate.
The interplay between the dynamic MLC-based delivery
of VMAT and the respiratory motion of the tumor may
degrade target coverage [27]. Since this is not a concern
with 3D technique, we expect a better agreement in target
coverage between the plan and delivered treatment for 3D
treatment compared to VMAT if there is significant
respiratory tumor motion or if the beam aperture size is
frequently small in a VMAT plan. We are currently
exploring the impact of tumor motion on target coverage
when using IMRT technique.
Conclusions
CI, CN and mean lung dose are highly statistically
improved for all studied VMAT techniques compared
with 3D plans. GI, V5 and V20 are statistically improved
for FFF-VMAT plans compared with 3D technique. It is
also clear that FFF-VMAT plans require more monitor
units than 3D or non-coplanar VMAT techniques.
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